Literature DB >> 15599123

Common questions and answers in the management of hypertension: routine measurement of plasma renin activity in the management of patients with essential hypertension: notes from the 19th Annual ASH Meeting.

Ari Mosenkis1, Raymond R Townsend.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599123      PMCID: PMC8109314          DOI: 10.1111/j.1076-7460.2004.04241.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  4 in total

1.  Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.

Authors:  Jan Laws Houghton
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

2.  Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension.

Authors:  J D Blumenfeld; J H Laragh
Journal:  Am J Hypertens       Date:  1998-07       Impact factor: 2.689

3.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

4.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

  4 in total
  1 in total

1.  Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated Hypertension.

Authors:  Mai Mehanna; Zhiying Wang; Yan Gong; Caitrin W McDonough; Amber L Beitelshees; John G Gums; Arlene B Chapman; Gary L Schwartz; Kent R Bailey; Julie A Johnson; Stephen T Turner; Rhonda M Cooper-DeHoff
Journal:  Am J Hypertens       Date:  2019-06-11       Impact factor: 3.080

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.